ICCM - IceCure Medical Ltd

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/24/2023
Current
3/31/202312/31/20229/30/20226/30/20223/31/2022
Market Cap (intraday)
53.88M52.40M69.30M45.58M63.36M87.17M
Enterprise Value
48.82M29.34M55.78M28.59M41.86M83.97M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
15.2513.8015.7412.4816.1510.06
Price/Book (mrq)
2.462.064.632.522.7418.74
Enterprise Value/Revenue
15.8341.3359.4045.0954.71112.41
Enterprise Value/EBITDA
-2.96-7.57-14.46-7.09-9.90-19.20

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3-41.94%
S&P500 52-Week Change 31.77%
52 Week High 34.7300
52 Week Low 30.7500
50-Day Moving Average 31.1975
200-Day Moving Average 31.2807

Share Statistics

Avg Vol (3 month) 3180.26k
Avg Vol (10 day) 3126.86k
Shares Outstanding 545.62M
Implied Shares Outstanding 6N/A
Float 817.61M
% Held by Insiders 147.00%
% Held by Institutions 10.80%
Shares Short (May 14, 2023) 4264.02k
Short Ratio (May 14, 2023) 41.32
Short % of Float (May 14, 2023) 41.31%
Short % of Shares Outstanding (May 14, 2023) 40.58%
Shares Short (prior month Apr 13, 2023) 4287.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-542.59%

Management Effectiveness

Return on Assets (ttm)-33.50%
Return on Equity (ttm)-64.83%

Income Statement

Revenue (ttm)3.08M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-32.20%
Gross Profit (ttm)1.45M
EBITDA -16.49M
Net Income Avi to Common (ttm)-16.98M
Diluted EPS (ttm)-0.3900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.66M
Total Cash Per Share (mrq)0.52
Total Debt (mrq)597k
Total Debt/Equity (mrq)2.35
Current Ratio (mrq)6.49
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-14.29M
Levered Free Cash Flow (ttm)-8.79M